Skip to main content
Clinical Trials/NCT06242561
NCT06242561CompletedNot Applicable

Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study: a Preliminary Retrospective Study

Centre Hospitalier Régional Metz-Thionville1 site in 1 country208 target enrollmentStarted: June 1, 2023Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
208
Locations
1
Primary Endpoint
Total volume of fluids administered during the first 48 hours of ICU stay

Study Overview

Brief Summary

This is a single-center retrospective study conducted at Mercy hospital, aiming to investigate the correlation between changes in hemoglobin (Hb) levels and the volume of vascular refill administered during the first 48 hours.

Detailed Description

Vascular refill is central to the initial management of hypotension in sepsis, and is often started even before the patient is admitted to intensive care. Over the past 20 years, we have moved from ultraliberal fluid resuscitation to restrictive resuscitation. Indeed, in the early 2000s, the implementation of an early and aggressive hemodynamic optimization strategy, including liberal vascular filling, improved the survival of critically ill patients, and ushered in the era of the Surviving Sepsis Campaign. However, studies have shown increased morbidity and mortality associated with a positive fluid balance. Restrictive approaches to fluid resuscitation and/or deressuscitation were then tested. While these approaches failed to demonstrate any benefit in terms of mortality, they did have the merit of demonstrating their feasibility and good tolerability, albeit with a little-explored pathophysiology. Little is known about the problem of dilutional anemia in the acute phase of septic shock.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Retrospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients with septic shock, admitted to Mercy hospital between November 1, 2022 and July 31, 2023, with Noradrenaline administration for at least 6 hours and at least 2 hemoglobin measurements during the first 48 hours of resuscitation.

Exclusion Criteria

  • patients with acute bleeding or blood transfusion before or during the first 48 hours of resuscitation.

Outcomes

Primary Outcomes

Total volume of fluids administered during the first 48 hours of ICU stay

Time Frame: 48 hours from ICU admission

Total volume of fluids (ml)

Secondary Outcomes

  • Length of hospital stay(at hospital discharge : an average of 15 days)
  • In hospital mortality(at hospital discharge : an average of 15 days)
  • Haemoglobinemia(48 hours from ICU admission)
  • Volume of fluids administered before admission in ICU (ml)(at ICU admission)
  • Type of fluids administered during the first 48 hours of ICU stay(48 hours from ICU admission)

Investigators

Sponsor
Centre Hospitalier Régional Metz-Thionville
Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Quantification of Dilutional Anemia in the... | Clinical Trial